Aaliya Wears All These Hats … and More Lupus Advocate. Human Rights Defender. Teenager. Aaliya Wears All These Hats … and More It takes a brave, compassionate person to look beyond the personal pain of lupus and look for ways to create greater good. And it is even more remarkable when that person is a […] READ MORE
We can’t imagine November without all of you, so we reimagined our annual gala celebration—online. Using the very latest technology, the Lupus Research Alliance will host an unparalleled virtual event featuring inspirational speakers, star-studded performances, surprise celebrity guests, and recognition of the extraordinary contributions of Jenny and Spencer Zwick of Solamere Capital and the LRA […] READ MORE
Fall, 2020 If you are employed by the Federal Government — a federal, postal, or military employee — you have a special chance to help transform the lives of people with lupus. Last year, through the Combined Federal Campaign (CFC), thousands of federal employees pledged more than $86.4 million to worthy causes including the Lupus […] READ MORE
NEW YORK, NY, November 9, 2020. The Lupus Research Alliance proudly announced today the 2020 Lupus Innovation Award recipients. These seven projects represent a wide breadth of scientific exploration in lupus, probing the development and progression of lupus while pointing to potential treatment approaches. The Lupus Innovation Award offers up to $150,000/year total costs for […] READ MORE
Join the Lupus Research Alliance in partnership with Handwritten Wines of Yountville, California for our Virtual Pour for A Cure – Taste Wine and Fight Lupus event, all from the comfort of your home. Since we cannot be together physically, let us get together virtually and enjoy an intimate wine tasting experience you will always […] READ MORE
October 22, 2020 Aurinia Pharmaceuticals announced that data taken from a combined analysis of two trials, AURA-LV and AURORA underscored the potential for voclosporin to offer a tool to treat lupus nephritis. Results from 534 patients from both trials was presented at the American Society of Nephrology Kidney Week 2020 meeting by Dr. Brad Rovin, […] READ MORE
October 22, 2020 Great event; I learned a lot and will have a discussion with my doctor about participating in a trial. It was excellent, and the website is very easy to use. I learned that the medicines you take for lupus are not designed for the disease while the ones you take in a […] READ MORE
October 22, 2020 To take or not to take the COVID-19 vaccine when one is available — that is the question on everyone’s minds, and we need all of your answers to accurately represent people with lupus and their supporters! As coronavirus vaccines are being developed and tested, the Lupus Research Alliance recently convened a […] READ MORE
October 21, 2020 In a recent study published in Nature Immunology, LRA Lupus Insight Prize recipient Dr. Ignacio Sanz and colleagues found that the immune response in patients hospitalized with severe COVID-19 was different from that in patients with mild disease, and that the immune response in severely ill COVID-19 patients was more like a lupus flare. They saw that among severely ill COVID-19 patients, some immune cells called B cells reproduced unchecked, and […] READ MORE
October 15, 2020 Some people respond to COVID-19 by releasing high amounts of immune proteins called cytokines, which form when the body detects a foreign invader. But release of excessive amounts of cytokines leads to a large immune response that can cause organ damage. With grant support from the Lupus Research Alliance, Dr. Roberto Caricchio […] READ MORE
October 8, 2020 People with lupus often develop complications in major organs such as the kidneys, called Lupus Nephritis (LN). By taking pictures of the kidneys with a special microscope, Dr. Janos Peti-Peterdi and his team at Keck School of Medicine of University of Southern California (USC) found a chain of molecules that leads to […] READ MORE
October 1, 2020 In a recent Lupus Research Alliance supported study published in Frontiers in Immunology, Dr. Ziaur Rahman linked molecules called TLR7 and type II interferon to impairing the ability of immune cells to do their job. These findings support further development by several companies of lupus treatments that block TLR7 and type II […] READ MORE
